{"count":6,"next":null,"previous":null,"results":[{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Radboud University Medical Center, Nijmegen","UKGTN","Illumina TruGenome Clinical Sequencing Services"],"phenotypes":["Frontotemporal Dementia","Dementia, familial, nonspecific, 600795Amyotrophic lateral sclerosis 17, 614696"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":265,"hash_id":"55b6173522c1fc05fc7a1855","name":"Early onset dementia (encompassing fronto-temporal dementia and prion disease)","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodegenerative disorders","status":"public","version":"1.48","version_created":"2019-06-20T15:15:01.659131Z","relevant_disorders":[],"stats":{"number_of_genes":31,"number_of_strs":9,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Emory Genetics Laboratory"],"phenotypes":["Dystonia","Frontotemporal dementia and/or amyotrophic lateral sclerosis 1","familial frontotemporal lobar degeneration (ALS17)"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":192,"hash_id":"553f95c9bb5a1616e5ed45bf","name":"Early onset dystonia","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Motor Disorders of the CNS","status":"public","version":"1.81","version_created":"2019-09-23T11:22:14.418180Z","relevant_disorders":[],"stats":{"number_of_genes":111,"number_of_strs":4,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green"],"phenotypes":["familial frontotemporal lobar degeneration (ALS17)","Dystonia","Frontotemporal dementia and/or amyotrophic lateral sclerosis 1"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":475,"hash_id":null,"name":"Dystonia - childhood onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.8","version_created":"2019-09-09T13:17:58.240159Z","relevant_disorders":[],"stats":{"number_of_genes":176,"number_of_strs":7,"number_of_regions":1},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["16041373","20352044","17956895"],"evidence":["Wessex and West Midlands GLH","Yorkshire and North East GLH","NHS GMS","London North GLH","Expert Review Green"],"phenotypes":["familial frontotemporal lobar degeneration (ALS17)","Dystonia","Frontotemporal Dementia","Frontotemporal dementia and/or amyotrophic lateral sclerosis 1","Dementia, familial, nonspecific, 600795","Dementia, familial, nonspecific, 600795Amyotrophic lateral sclerosis 17, 614696","Amyotrophic lateral sclerosis 17, 614696"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":474,"hash_id":null,"name":"Neurodegenerative disorders - adult onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.106","version_created":"2019-09-20T16:19:10.101841Z","relevant_disorders":["R58"],"stats":{"number_of_genes":395,"number_of_strs":18,"number_of_regions":4},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"Other - please provide details in the comments","publications":["PMID: 20352044 - \"We conclude that in a population drawn from North of England pathogenic CHMP2B mutations are found in approximately 1% of cases of ALS and 10% of those with lower motor neuron predominant ALS. We provide a body of evidence indicating the likely pathogenicity of the reported gene alterations. However, absolute confirmation of pathogenicity requires further evidence, including documentation of familial transmission in ALS pedigrees which might be most fruitfully explored in cases with a LMN predominant phenotype.\""],"evidence":["Expert Review Red","Radboud University Medical Center, Nijmegen"],"phenotypes":["Dementia, familial, nonspecific, 600795","Amyotrophic lateral sclerosis 17, 614696"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":263,"hash_id":"55d30b0322c1fc2ff2a5bf7b","name":"Amyotrophic lateral sclerosis/motor neuron disease","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodegenerative disorders","status":"public","version":"1.29","version_created":"2019-06-20T15:14:55.521778Z","relevant_disorders":["Amyotrophic lateral sclerosis or motor neuron disease"],"stats":{"number_of_genes":30,"number_of_strs":4,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["DKFZP564O123","CHMP2.5","VPS2B"],"biotype":"protein_coding","hgnc_id":"HGNC:24537","gene_name":"charged multivesicular body protein 2B","omim_gene":["609512"],"alias_name":["VPS2 homolog B (S. cerevisiae)"],"gene_symbol":"CHMP2B","hgnc_symbol":"CHMP2B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"3:87276421-87304698","ensembl_id":"ENSG00000083937"}},"GRch38":{"90":{"location":"3:87227271-87255548","ensembl_id":"ENSG00000083937"}}},"hgnc_date_symbol_changed":"2005-04-04"},"entity_type":"gene","entity_name":"CHMP2B","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS","London North GLH","Expert Review Green"],"phenotypes":["familial frontotemporal lobar degeneration (ALS17)","Dystonia","Frontotemporal dementia and/or amyotrophic lateral sclerosis 1"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":540,"hash_id":null,"name":"Adult onset movement disorder","disease_group":"","disease_sub_group":"","status":"public","version":"0.125","version_created":"2019-09-29T14:25:05.513850Z","relevant_disorders":["R56"],"stats":{"number_of_genes":202,"number_of_strs":11,"number_of_regions":1},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}}]}